| 1 |
10372954 | Neuroendocrine responses to intravenous infusion of physostigmine in patients with Alzheimer disease. | 1999 Apr-Jun |
2 |
| 2 |
7890023 | Cholinergic potentiation of the meal-related rise in ACTH and cortisol concentrations in men. | 1994 |
1 |
| 3 |
2525015 | Neuroendocrine responses to physostigmine in Alzheimer's disease. | 1989 Jun |
1 |
| 4 |
2526916 | Physostigmine induced beta-endorphin release as a mechanism for physostigmine management of early alcohol withdrawal. | 1989 Jun |
4 |
| 5 |
22155841 | The scopolamine model of dementia: determination of central cholinomimetic effects of physostigmine on cognition and biochemical markers in man. | 1988 Jan |
2 |
| 6 |
3018822 | Central and peripheral cholinesterase inhibition: effects on anterior pituitary and sympathomimetic function. | 1986 |
3 |
| 7 |
6319456 | Analysis of the specificity of physostigmine stimulation of adrenocorticotropin in man. | 1984 Mar |
3 |
| 8 |
6487203 | A cholinomimetic model of motion sickness and space adaptation syndrome. | 1984 Aug |
2 |
| 9 |
6318208 | Muscarinic supersensitivity of anterior pituitary ACTH and B-endorphin release in major depressive illness. | 1983 Sep-Oct |
1 |
| 10 |
6289276 | Correlated cholinomimetic-stimulated beta-endorphin and prolactin release in humans. | 1982 May-Jun |
2 |
| 11 |
6293594 | beta-Endorphin hypersecretion in depression: possible cholinergic mechanisms. | 1982 Oct |
1 |
| 12 |
7433977 | Mood and behavioral effects of physostigmine on humans are accompanied by elevations in plasma beta-endorphin and cortisol. | 1980 Sep 26 |
3 |